Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients-Reference-Cited by-同舟云学术

Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients

Published:2019-08 Issue: Volume:342 Page:103780
ISSN:0008-8749
Container-title:Cellular Immunology
language:en
Short-container-title:Cellular Immunology

Author:

Leborgne Christian,Latournerie Virginie,Boutin Sylvie,Desgue Diana,Quéré Aliénor,Pignot Elodie,Collaud Fanny,Charles Séverine,Simon Sola Marcelo,Masat Elisa,Jouen Fabienne,Boyer Olivier^ORCID,Masurier Carole,Mingozzi Federico,Veron Philippe

Funder

European Union

Publisher

Elsevier BV

Subject

Immunology

Reference69 articles.

1. Duchenne muscular dystrophy–Meryon’s disease;Emery;Neuromuscul. Disord.,1993

2. Edward Meryon (1809–1880) and muscular dystrophy;Emery;J. Med. Genet.,1993

3. Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy;Griggs;Neurology,2016

4. Eteplirsen in the treatment of Duchenne muscular dystrophy;Lim;Drug Des. Dev. Ther.,2017

5. Evidence-based path to newborn screening for Duchenne muscular dystrophy;Mendell;Ann. Neurol.,2012

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroprevalence of adeno-associated virus types 1, 2, 3, 4, 5, 6, 8, and 9 in a Basque cohort of healthy donors;Scientific Reports;2024-07-10

2. Preexisting maternal immunity to AAV but not Cas9 impairs in utero gene editing in mice;Journal of Clinical Investigation;2024-05-09

3. The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution;Medicinal Research Reviews;2024-03-28

4. Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia;Gene Therapy;2024-02-14

5. Understanding AAV vector immunogenicity: from particle to patient;Theranostics;2024